Lv5
1150 积分 2021-12-10 加入
First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma
9小时前
已完结
Resistance Profile and Structural Modeling of Next-Generation ROS1 Tyrosine Kinase Inhibitors
16天前
已完结
ROS1-positive non-small cell lung cancer (NSCLC): biology, diagnostics, therapeutics and resistance
16天前
已完结
Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions
22天前
已完结
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma
28天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
1个月前
已完结
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma
1个月前
已完结
Belzutifan (MK-6482): Biology and Clinical Development in Solid Tumors
1个月前
已完结
Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors
3个月前
已完结
T-cell-engaging bispecific antibodies in cancer
3个月前
已完结
皖公网安备34019202002308
